全文获取类型
收费全文 | 2150篇 |
免费 | 148篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 30篇 |
儿科学 | 62篇 |
妇产科学 | 43篇 |
基础医学 | 331篇 |
口腔科学 | 52篇 |
临床医学 | 165篇 |
内科学 | 380篇 |
皮肤病学 | 45篇 |
神经病学 | 348篇 |
特种医学 | 103篇 |
外科学 | 242篇 |
综合类 | 8篇 |
一般理论 | 2篇 |
预防医学 | 153篇 |
眼科学 | 46篇 |
药学 | 170篇 |
中国医学 | 2篇 |
肿瘤学 | 128篇 |
出版年
2024年 | 5篇 |
2023年 | 23篇 |
2022年 | 34篇 |
2021年 | 62篇 |
2020年 | 49篇 |
2019年 | 50篇 |
2018年 | 58篇 |
2017年 | 37篇 |
2016年 | 72篇 |
2015年 | 73篇 |
2014年 | 96篇 |
2013年 | 94篇 |
2012年 | 149篇 |
2011年 | 200篇 |
2010年 | 103篇 |
2009年 | 105篇 |
2008年 | 129篇 |
2007年 | 116篇 |
2006年 | 108篇 |
2005年 | 97篇 |
2004年 | 89篇 |
2003年 | 69篇 |
2002年 | 66篇 |
2001年 | 37篇 |
2000年 | 34篇 |
1999年 | 27篇 |
1998年 | 13篇 |
1997年 | 17篇 |
1996年 | 11篇 |
1995年 | 7篇 |
1993年 | 5篇 |
1992年 | 15篇 |
1991年 | 14篇 |
1990年 | 24篇 |
1989年 | 21篇 |
1988年 | 10篇 |
1987年 | 13篇 |
1986年 | 10篇 |
1985年 | 13篇 |
1984年 | 8篇 |
1983年 | 9篇 |
1982年 | 11篇 |
1979年 | 8篇 |
1978年 | 7篇 |
1974年 | 13篇 |
1973年 | 6篇 |
1972年 | 9篇 |
1971年 | 8篇 |
1970年 | 6篇 |
1959年 | 5篇 |
排序方式: 共有2310条查询结果,搜索用时 0 毫秒
101.
Traunmüller F Zeitlinger MA Stoiser B Lagler H Abdel Salam HA Presterl E Graninger W 《Scandinavian journal of infectious diseases》2003,35(11-12):790-793
Tuberculostearic acid (TBSA), a mycobacterial cell wall constituent, was measured in plasma samples using a highly sensitive high-performance liquid chromatography method. Plasma TBSA concentrations in patients with active tuberculosis (20 [0.5-347] nmol/l; n = 125) were higher than in patients with a variety of non-tuberculous pulmonary and extrapulmonary inflammatory conditions (0.1 [0-29] nmol/l; n = 116) and in healthy controls (0 [0-2] nmol/l; n = 102) (p = < 0.001). The calculated sensitivity, specificity, positive and negative predictive values for tuberculosis were 95.2%, 87.9%, 89.5% and 94.4%, respectively, indicating that assay of plasma TBSA might be a valuable complementary diagnostic tool. 相似文献
102.
Moeller K 《Der Unfallchirurg》2002,105(3):275-277
We report about a 36 year old patient with insufficient silicone implant arthroplasty of the great toe. For a change of endoprothesis we successfully used an non-cemented modular alloarthroplasty system. 相似文献
103.
Trost M Carbon M Edwards C Ma Y Raymond D Mentis MJ Moeller JR Bressman SB Eidelberg D 《Annals of neurology》2002,52(6):853-856
The DYT1 dystonia mutation is associated with an abnormal metabolic brain network characterized by hypermetabolism of the basal ganglia, supplementary motor area, and the cerebellum. In this study, we quantified the activity of this network in carriers of other dystonia mutations to determine whether this functional abnormality is linked to genotype. The findings suggest that the DYT1 metabolic topography is not genotype specific and may be present in carriers of other dystonia mutations. 相似文献
104.
105.
CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects 总被引:13,自引:0,他引:13
Buerger K Teipel SJ Zinkowski R Blennow K Arai H Engel R Hofmann-Kiefer K McCulloch C Ptok U Heun R Andreasen N DeBernardis J Kerkman D Moeller H Davies P Hampel H 《Neurology》2002,59(4):627-629
In this longitudinal study of 77 patients with mild cognitive impairment (MCI), the authors analyzed whether levels of tau protein phosphorylated at threonine 231 (p-tau(231)) in CSF correlate with progression of cognitive decline. High CSF p-tau(231) levels at baseline, but not total tau protein levels, correlated with cognitive decline and conversion from MCI to AD. Independently, old age and APOE-epsilon 4 carrier status were predictive as well. Our data indicate that an increased p-tau(231) level is a potential risk factor for cognitive decline in patients with MCI. 相似文献
106.
107.
BACKGROUND: Recent guidelines for length of stay at psychiatric hospitals may have an unacceptable impact on patient outcome at discharge. A valid measurement tool is needed to evaluate significant patient change during brief hospitalization, typically 7 days, and to provide early prediction of unfavorable short-term outcome. This study examines the utility of the Brief Psychiatric Rating Scale (BPRS) as such a tool. METHOD: During a 2-month testing period, the BPRS was administered to 87 successive adults admitted to an acute general psychiatric inpatient unit at admission, 2 days, 7 days, and weekly thereafter until discharge. Total BPRS scores and 4 subscores were used in the data analysis, which included paired t tests and correlation analyses. RESULTS: Mean BPRS total scores demonstrate significant (p < .001) patient improvement at days 2, 7, and 14 of the hospital stay. Changes in subscores and their relationship to eventual outcome vary across diagnostic groups. CONCLUSION: The BPRS appears to be a useful inpatient outcome measure since it is capable of demonstrating significant change during brief stays of 1 week or less. Subscale scores may provide more specific prediction of change and may help clarify outcome in individual patients who show insignificant change by total score. 相似文献
108.
Ebbesen F Joergensen A Hoseth E Kaad PH Moeller M Holsteen V Rix M 《Archives of disease in childhood. Fetal and neonatal edition》2000,83(2):F124-F129
AIMS: To define, in a prospective study, the risk of hypoglycaemia-defined as blood glucose concentration < 1.8 mmol/l-in term infants exposed in utero to valproate and to describe the withdrawal symptoms. METHODS: Twenty epileptic women were treated with valproate only during pregnancy and two were treated with valproate and carbamazepine. In the first trimester, the daily median dose of valproate was 1.0 g (range 0.3-4.2) and in the third trimester 1.2 g (range 0.3-4.8). RESULTS: Thirteen of the 22 infants became hypoglycaemic. One infant had eight episodes of hypoglycaemia, one had three episodes, two had two episodes, and nine had one episode each. The lowest blood glucose concentration was 1.0 mmol/l. All episodes were asymptomatic. The maternal mean plasma concentration of total valproate during the third trimester correlated negatively with blood glucose concentration one hour after delivery (p < 0.0003) and with the development of hypoglycaemia (p < 0.0001). There was no evidence for hyperinsulinaemia as the cause of hypoglycaemia. Ten infants developed withdrawal symptoms, which correlated positively with the mean dose of valproate in the third trimester and the concentration of the free fraction of valproate in maternal plasma at delivery (p < 0.02). CONCLUSIONS: Infants exposed to valproate in utero had a significantly elevated risk of hypoglycaemia, and withdrawal symptoms were often observed. 相似文献
109.
Anthracyclines serve as a valuable tool in chemotherapy, but their usefulness is often limited by the occurrence of resistance mechanisms in tumor cells. Resistance of tumor cells is a multifactorial event, where several mechanisms act concurrently, including drug efflux and enzymatic drug inactivation. Liposomal encapsulation of anthracyclines has been discussed as a successful regimen to overcome drug resistance. Our investigations were carried out on a daunorubicin (DRC) sensitive breast cancer cell line and two DRC resistant sublines generated thereof. In all three cell lines, the extent of DRC detoxification via carbonyl reduction to daunorubicinol (DRCOL) was determined. In addition, rutin, the most effective inhibitor of carbonyl reducing enzymes, was tested to affect DRCOL formation. DRC IC(50) values were determined in relation to several combinations of DRC administration, (a) liposomal encapsulated DRC, (b) addition of verapamil (inhibitor of drug efflux), (c) addition of rutin (inhibitor of DRC carbonyl reduction). We could show that DRC sensitive and resistant breast cancer cell lines are able to catalyze DRC detoxification via carbonyl reduction to DRCOL. Rutin was shown to inhibit this reaction, but could not serve as an enhancer of DRC toxicity in MTT tests. Verapamil was effective only in resistant cells due to the overexpression of P-glycoprotein 170. Liposomal encapsulation of DRC did not show the expected increase in DRC toxicity in the present tumor cell model. 相似文献
110.